Display options
Cite
Lu S, Bennett RG, Kharbanda KK, et al. Lack of hepcidin expression attenuates steatosis and causes fibrosis in the liver. World J Hepatol. 2016;8(4):211-25doi: 10.4254/wjh.v8.i4.211.
Lu, S., Bennett, R. G., Kharbanda, K. K., & Harrison-Findik, D. D. (2016). Lack of hepcidin expression attenuates steatosis and causes fibrosis in the liver. World journal of hepatology, 8(4), 211-25. https://doi.org/10.4254/wjh.v8.i4.211
Lu, Sizhao, et al. "Lack of hepcidin expression attenuates steatosis and causes fibrosis in the liver." World journal of hepatology vol. 8,4 (2016): 211-25. doi: https://doi.org/10.4254/wjh.v8.i4.211
Lu S, Bennett RG, Kharbanda KK, Harrison-Findik DD. Lack of hepcidin expression attenuates steatosis and causes fibrosis in the liver. World J Hepatol. 2016 Feb 08;8(4):211-25. doi: 10.4254/wjh.v8.i4.211. PMID: 26855692; PMCID: PMC4733464.
Copy Download .nbib Format: NLM
Share it on

World J Hepatol. 2016 Feb 08;8(4):211-25. doi: 10.4254/wjh.v8.i4.211.

Lack of hepcidin expression attenuates steatosis and causes fibrosis in the liver.

World journal of hepatology

Sizhao Lu, Robert G Bennett, Kusum K Kharbanda, Duygu Dee Harrison-Findik

Affiliations

  1. Sizhao Lu, Robert G Bennett, Department of Biochemistry, University of Nebraska Medical Center, Omaha, NE 68198-5870, United States.

PMID: 26855692 PMCID: PMC4733464 DOI: 10.4254/wjh.v8.i4.211

Abstract

AIM: To investigate the role of key iron-regulatory protein, hepcidin in non-alcoholic fatty liver disease (NAFLD).

METHODS: Hepcidin (Hamp1) knockout and floxed control mice were administered a high fat and high sucrose (HFS) or a regular control diet for 3 or 7 mo. Steatosis, triglycerides, fibrosis, protein and gene expression in mice livers were determined by histological and biochemical techniques, western blotting and real-time polymerase chain reaction.

RESULTS: Knockout mice exhibited hepatic iron accumulation. Despite similar weight gains, HFS feeding induced hepatomegaly in floxed, but not knockout, mice. The livers of floxed mice exhibited higher levels of steatosis, triglycerides and c-Jun N-terminal kinase (JNK) phosphorylation than knockout mice. In contrast, a significant increase in fibrosis was observed in knockout mice livers within 3 mo of HFS administration. The hepatic gene expression levels of sterol regulatory element-binding protein-1c and fat-specific protein-27, but not peroxisome proliferator-activated receptor-alpha or microsomal triglyceride transfer protein, were attenuated in HFS-fed knockout mice. Knockout mice fed with regular diet displayed increased carnitine palmitoyltransferase-1a and phosphoenolpyruvate carboxykinase-1 but decreased glucose-6-phosphatase expression in the liver. In summary, attenuated steatosis correlated with decreased expression of lipogenic and lipid storage genes, and JNK phosphorylation. Deletion of Hamp1 alleles per se modulated hepatic expression of beta-oxidation and gluconeogenic genes.

CONCLUSION: Lack of hepcidin expression inhibits hepatic lipid accumulation and induces early development of fibrosis following high fat intake. Hepcidin and iron may play a role in the regulation of metabolic pathways in the liver, which has implications for NAFLD pathogenesis.

Keywords: Hamp; Iron; Metabolic genes; Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis; Steatohepatitis; Steatosis

References

  1. Am J Gastroenterol. 1999 Sep;94(9):2467-74 - PubMed
  2. Hepatology. 2011 Apr;53(4):1333-41 - PubMed
  3. Proc Natl Acad Sci U S A. 2003 Mar 18;100(6):3077-82 - PubMed
  4. Int J Mol Sci. 2013 Oct 15;14(10):20704-28 - PubMed
  5. Curr Opin Cell Biol. 1998 Apr;10(2):205-19 - PubMed
  6. Trends Endocrinol Metab. 2010 Dec;21(12):707-13 - PubMed
  7. Hepatology. 2010 Feb;51(2):679-89 - PubMed
  8. Curr Opin Lipidol. 2009 Apr;20(2):121-6 - PubMed
  9. Hepatology. 2011 Feb;53(2):448-57 - PubMed
  10. Hepatology. 2007 Dec;46(6):1979-85 - PubMed
  11. Am J Clin Nutr. 2008 May;87(5):1374-83 - PubMed
  12. Am J Physiol Gastrointest Liver Physiol. 2012 Jun 15;302(12):G1397-404 - PubMed
  13. Nat Rev Gastroenterol Hepatol. 2013 Nov;10(11):627-36 - PubMed
  14. Hepatology. 2007 Jun;45(6):1366-74 - PubMed
  15. World J Gastroenterol. 2012 Sep 14;18(34):4651-8 - PubMed
  16. Genes Nutr. 2012 Jul;7(3):415-25 - PubMed
  17. World J Gastroenterol. 2013 Feb 28;19(8):1158-65 - PubMed
  18. Eur J Biochem. 2004 Feb;271(3):462-9 - PubMed
  19. Blood. 2004 Apr 1;103(7):2816-21 - PubMed
  20. J Gastroenterol Hepatol. 2008 Nov;23(11):1635-48 - PubMed
  21. PLoS One. 2012;7(10 ):e48250 - PubMed
  22. J Hepatol. 2015 Mar;62(3):720-33 - PubMed
  23. World J Hepatol. 2015 Feb 27;7(2):177-88 - PubMed
  24. J Hepatol. 1997 Mar;26(3):584-92 - PubMed
  25. Hepatology. 2009 Jan;49(1):87-96 - PubMed
  26. Physiol Rev. 2013 Oct;93(4):1721-41 - PubMed
  27. Diabet Med. 2013 Dec;30(12):1495-9 - PubMed
  28. J Mol Med (Berl). 2009 Jul;87(7):679-95 - PubMed
  29. J Clin Invest. 2012 Oct;122(10 ):3529-40 - PubMed
  30. Dig Dis. 2010;28(1):247-54 - PubMed
  31. Mitochondrion. 2006 Feb;6(1):1-28 - PubMed
  32. J Biol Chem. 2001 Mar 16;276(11):7811-9 - PubMed
  33. Compr Physiol. 2014 Jan;4(1):177-97 - PubMed
  34. Blood. 2006 Aug 15;108(4):1402-5 - PubMed
  35. Br J Haematol. 2008 Sep;142(6):979-85 - PubMed
  36. Hepatology. 2006 Oct;44(4):865-73 - PubMed
  37. Transgenic Res. 2015 Aug;24(4):765-73 - PubMed
  38. Liver Int. 2006 Dec;26(10):1258-67 - PubMed
  39. Hepatology. 2011 Jul;54(1):273-84 - PubMed
  40. Histochem J. 1979 Jul;11(4):447-55 - PubMed
  41. Proc Natl Acad Sci U S A. 2010 Jun 15;107(24):10775-82 - PubMed
  42. Hepatol Int. 2012 Jan;6(1):332-41 - PubMed
  43. Gastroenterology. 2014 Apr;146(4):1060-9 - PubMed
  44. QJM. 2010 Feb;103(2):71-83 - PubMed
  45. Metab Syndr Relat Disord. 2011 Aug;9(4):287-90 - PubMed
  46. Hepatology. 2012 Nov;56(5):1730-40 - PubMed
  47. Biochim Biophys Acta. 2012 Sep;1823(9):1434-43 - PubMed
  48. Am J Gastroenterol. 2007 Jun;102(6):1251-8 - PubMed
  49. Proc Natl Acad Sci U S A. 2004 Aug 3;101(31):11245-50 - PubMed
  50. J Biol Chem. 2000 Oct 6;275(40):31078-85 - PubMed
  51. Lipids. 1978 Jul;13(7):473-8 - PubMed
  52. Horm Res Paediatr. 2013;80(1):11-7 - PubMed
  53. Int J Mol Sci. 2013 Nov 04;14(11):21833-57 - PubMed
  54. Clin Lipidol. 2011 Jun;6(3):293-303 - PubMed
  55. Hepatology. 2006 Jan;43(1):163-72 - PubMed
  56. Proc Natl Acad Sci U S A. 2001 Jul 17;98 (15):8780-5 - PubMed
  57. Gastroenterology. 2006 Sep;131(3):788-96 - PubMed
  58. Gastroenterology. 1998 Apr;114(4):842-5 - PubMed
  59. J Hepatol. 2014 Sep;61(3):633-41 - PubMed
  60. Mol Endocrinol. 2002 May;16(5):1013-28 - PubMed
  61. Annu Rev Pathol. 2010;5:145-71 - PubMed
  62. J Biol Chem. 1957 May;226(1):497-509 - PubMed
  63. J Nutr Biochem. 2013 Sep;24(9):1634-44 - PubMed
  64. Gastroenterology. 2010 Mar;138(3):905-12 - PubMed
  65. J Nutr. 1987 Sep;117(9):1514-9 - PubMed
  66. J Clin Invest. 2004 Jul;114(2):147-52 - PubMed
  67. Nat Rev Gastroenterol Hepatol. 2013 Jun;10(6):330-44 - PubMed
  68. Annu Rev Med. 2002;53:409-35 - PubMed
  69. J Nutr. 1978 Jan;108(1):152-62 - PubMed
  70. Science. 2004 Dec 17;306(5704):2090-3 - PubMed
  71. Annu Rev Pathol. 2011;6:425-56 - PubMed

Publication Types

Grant support